CELG.RT
Bristol-Myers Squibb Company Contingent Value Rights
CELG.RT
CELG.RT
18 hedge funds and large institutions have $156K invested in Bristol-Myers Squibb Company Contingent Value Rights in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 0 closing their positions.
Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
FCM
1
FourWorld Capital Management
New York
|
$69K |
2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$8.09K |
Top Sellers
1 |
DC
1
Davenport & Co
Richmond,
Virginia
|
$10K |
2 |
2
Citadel Advisors
Miami,
Florida
|
$4.51K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$45 |
4 |
4
Bank of America
Charlotte,
North Carolina
|
$183 |